Targeting Senescent Cells for a Healthier Aging: Challenges and Opportunities
Open accessThe DOI matches its Crossref record; 163 of the 163 references it cites were found in a registry or an index.
Abstract
Aging is a physiological decline in both structural homeostasis and functional integrity, progressively affecting organismal health. A major hallmark of aging is the accumulation of senescent cells, which have entered a state of irreversible cell cycle arrest after experiencing inherent or environmental stresses. Although cellular senescence is essential in several physiological events, it plays a detrimental role in a large array of age‐related pathologies. Recent biomedical advances in specifically targeting senescent cells to improve healthy aging, or alternatively, postpone natural aging and age‐related diseases, a strategy termed senotherapy, have attracted substantial interest in both scientific and medical communities. Challenges for aging research are highlighted and potential avenues that can be leveraged for therapeutic interventions to control aging and age‐related disorders in the current era of precision medicine.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures
![Figure 1 The canonical hallmarks of aging, its accompanying chronic diseases and potential interventions. Aging is characterized by a set of typical hallmarks, including genomic instability, epigenetic alterations, mitochondrial dysfunction, loss of proteostasis, telomere attrition, deregulated nutrient sensing, stem cell exhaustion, and cellular senescence. During natural aging, the incidence of age‐related pathologies increases in a progressive manner, most of which implicate cellular senescence. Therapeutic avenues involving genetic, dietary, or pharmacologic approaches have emerged as potent intervention strategies to prevent or ameliorate aging symptoms, although with different mechanisms. Given that the aged population in a global range is drastically increasing and that aging outstands as the greatest risk factor for the vast majority of chronic diseases responsible for both morbidity and mortality, it is critical, urgent and sagacious to expand geroscience aimed at improving human healthspan. Note, the course of organismal aging is indeed accompanied by various natural activities such as revolution of planets in the universal setting, day and night (exemplified as symbols at the corners of the circle). Part of the figure (mainly the circle) is adapted with permission.[ 164 ] Copyright year 2020, CellPress.](https://figures.cochat.ai/paper-figures/664ca0a633c647179e3ccb12584b9894/targeting-senescent-cells-for-a-healthier-aging-challenges-and-opportunities-figure-1.jpg)
![Figure 2 Emerging strategies that showed efficacy in targeting cellular senescence. At late or advanced stages of life, senescent cells progressively accumulate in multiple tissue types and substantially promote the development of multiple age‐related diseases. Increasing lines of studies suggest that targeting specific fundamental mechanisms of aging may be more effective than treating each chronic pathology individually to restrain the impacts of aging on healthspan and lifespan. Pilot trials have been initiated to therapeutically target cellular senescence, such as A) selectively removing senescent cells via induction of their death (senolytic treatment), and B) engagement of the immune surveillance (senescence‐directed immunotherapy), with the potential of each strategy in depleting senescent cells from tissue microenvironment demonstrated by recent investigations. In each mechanistic illustration, yellow arrows mean stimulating or promotive actions, while red arrows represent suppressive or counteractive functions. A) Agents within yellow rectangles are example senolytics. B) Scissors represent shedding of NKG2D ligands by MMPs secreted by senescent cells, especially those induced by oncogene activation. (A) adapted with permission.[ 164 ] Copyright year 2020, CellPress. We stated “Figure (A) adapted with permission [164]. Copyright year 2020, CellPress.” Please refer to Page 33 (Figure legend, Figure 2).](https://figures.cochat.ai/paper-figures/13699244bcbb4d1e845514c41625c336/targeting-senescent-cells-for-a-healthier-aging-challenges-and-opportunities-figure-2.jpg)
![Figure 3 A hypothetic model to illustrate senotherapy‐mediated healthy aging. The first stage of the survival curve refers to the pre‐mortality plateau phase (PPP), during which ≈10% of the overall population is lost over a relatively long period. Alternatively referred to as a healthy lifespan, the PPP covers three sub‐stages, including an adolescent period when the body actively develops, a young adult period when the individual is physiologically mature, and a middle‐aged period when the mortality rate begins to increase. During the overall PPP span, 90% of the population remains alive, after which the mortality rate significantly arises and the population declines rapidly, a period constituting the late‐aged phase. However, in the case of senotherapy which theoretically comprises multiple waves of medications with senolytics administered in an intermittent or metronomic manner, the lifespan can be remarkably extended. Senotherapy can eliminate senescent cells, promote tissue repair, improve organ regeneration, and ameliorate multiple age‐related pathologies, thus providing a prominent avenue for a healthier aging of human populations.[ 165 , 166 ]](https://figures.cochat.ai/paper-figures/7ceb67ab1aad46f89474db600a12f54d/targeting-senescent-cells-for-a-healthier-aging-challenges-and-opportunities-figure-3.jpg)
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“The transition to cellular senescence can be initiated by a loss of epigenetic information, as well as telomere shortening, irreparable DNA damage, and cytoplasmic DNA [7, 10-12].”
From Chemically induced reprogramming to reverse cellular aging (2023) · cites this paper as [11]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Cellular senescence is a state of permanent cell cycle arrest that facilitates wound repair, tissue remodeling, and avoidance of cancer by halting proliferation in aged and damaged cells [10, 11].”
From Chemically induced reprogramming to reverse cellular aging (2023) · cites this paper as [11]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Sun, Y., Zhu, D., Chen, F., Qian, M., Wei, H., Chen, W., & Xu, J. (2016) · Oncogene · doi:10.1038/onc.2015.494 · Cited by 116
Self-citationRetractedCOVID-19: consider cytokine storm syndromes and immunosuppression
Mehta, P., McAuley, D. F., Brown, M., Sanchez, E., Tattersall, R. S., & Manson, J. J. (2020) · The Lancet · doi:10.1016/s0140-6736(20)30628-0 · Cited by 9,664
The serial cultivation of human diploid cell strains
Hayflick, L., & Moorhead, P. S. (1961) · Experimental Cell Research · doi:10.1016/0014-4827(61)90192-6 · Cited by 8,508
The limited in vitro lifetime of human diploid cell strains
Hayflick, L. (1965) · Experimental Cell Research · doi:10.1016/0014-4827(65)90211-9 · Cited by 5,876
Chronic inflammation in the etiology of disease across the life span
Furman, D., Campisi, J., Verdin, E., Carrera-Bastos, P., Targ, S., Franceschi, C., Ferrucci, L., Gilroy, D. W., Fasano, A., Miller, G. W., et al. (2019) · Nature Medicine · doi:10.1038/s41591-019-0675-0 · Cited by 4,915
Pleiotropy, natural selection, and the evolution of senescence.
Williams, G. C. (1957) · Evolution · doi:10.1111/j.1558-5646.1957.tb02911.x · Cited by 4,279
Clearance of p16Ink4a-positive senescent cells delays ageing-associated disorders
Baker, D. J., Wijshake, T., Tchkonia, T., LeBrasseur, N. K., Childs, B. G., van de Sluis, B., Kirkland, J. L., & van Deursen, J. M. (2011) · Nature · doi:10.1038/nature10600 · Cited by 3,670
Self-citationNaturally occurring p16Ink4a-positive cells shorten healthy lifespan
Baker, D. J., Childs, B. G., Durik, M., Wijers, M. E., Sieben, C. J., Zhong, J., A. Saltness, R., Jeganathan, K. B., Verzosa, G. C., Pezeshki, A., et al. (2016) · Nature · doi:10.1038/nature16932 · Cited by 2,876
Hallmarks of Cellular Senescence
Hernandez-Segura, A., Nehme, J., & Demaria, M. (2018) · Trends in Cell Biology · doi:10.1016/j.tcb.2018.02.001 · Cited by 2,605
The Achilles' heel of senescent cells: from transcriptome to senolytic drugs
Zhu, Y., Tchkonia, T., Pirtskhalava, T., Gower, A. C., Ding, H., Giorgadze, N., Palmer, A. K., Ikeno, Y., Hubbard, G. B., Lenburg, M., et al. (2015) · Aging Cell · doi:10.1111/acel.12344 · Cited by 2,584
Self-citation
Research works printed but not linked: 4
- C.‐L. Chen, Y.‐H. Chen, C.‐M. Liang, M.‐C. Tai, J.‐T. Chen, Int. J. Mol. Sci. 2018, 38, 16.
- Y. Sun, D. Zhu, F. Chen, M. Qian, H. Wei, W. Chen, J. Xu, Oncogene 2016, 35, 4321. 26751775 PMC4994019 · DOI · Paper page
- F. Triana‐Martínez, P. Picallos‐Rabina, S. Da Silva‐Álvarez, F. Pietrocola, S. Llanos, V. Rodilla, E. Soprano, P. Pedrosa, A. Ferreirós, M. Barradas, F. Hernández‐González, M. Lalinde, N. Prats, C. Bernadó, P. González, M. Gómez, M. P. Ikonomopoulou, P. J. Fernández‐Marcos, T. García‐Caballero, P. Del Pino, J. Arribas, A. Vidal, M. González‐Barcia, M. Serrano, M. I. Loza, E. Domínguez, M. Collado, Nat. Commun. 2019, 10, 4731. 31636264 PMC6803708 · DOI · Paper page
- W. Li, Y. He, R. Zhang, G. Zheng, D. Zhou, Aging 2019, 11, 771. 30694217 PMC6366974 · DOI · Paper page
Cited by
Epigenetic regulation of aging: implications for interventions of aging and diseases
Wang, K., Liu, H., Hu, Q., Wang, L., Liu, J., Zheng, Z., Zhang, W., Ren, J., Zhu, F., & Liu, G.-H. (2022) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-022-01211-8 · Cited by 663
Cai, Y., Song, W., Li, J., Jing, Y., Liang, C., Zhang, L., Zhang, X., Zhang, W., Liu, B., An, Y., et al. (2022) · Science China Life Sciences · doi:10.1007/s11427-022-2161-3 · Cited by 408
Self-citationAging Biomarker Consortium, Bao, H., Cao, J., Chen, M., Chen, M., Chen, W., Chen, X., Chen, Y., Chen, Y., Chen, Y., et al. (2023) · Science China Life Sciences · doi:10.1007/s11427-023-2305-0 · Cited by 376
Self-citationLagoumtzi, S. M., & Chondrogianni, N. (2021) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2021.05.003 · Cited by 279
Aging Hallmarks and Progression and Age-Related Diseases: A Landscape View of Research Advancement
Tenchov, R., Sasso, J. M., Wang, X., & Zhou, Q. A. (2024) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.3c00531 · Cited by 276
Han, Y., & Kim, S. Y. (2023) · Experimental & Molecular Medicine · doi:10.1038/s12276-022-00906-w · Cited by 201
Chen, M., Wang, D., Li, M., He, Y., He, T., Chen, M., Hu, Y., Luo, Z. Y., & Cai, K. (2022) · ACS Nano · doi:10.1021/acsnano.2c07200 · Cited by 152
Chemically induced reprogramming to reverse cellular aging
Yang, J.-H., Petty, C. A., Dixon-McDougall, T., Lopez, M. V., Tyshkovskiy, A., Maybury-Lewis, S., Tian, X., Ibrahim, N., Chen, Z., Griffin, P. T., et al. (2023) · Aging · doi:10.18632/aging.204896 · Cited by 136
Liu, H., Xu, Q., Wufuer, H., Li, Z., Sun, R., Jiang, Z., Dou, X., Fu, Q., Campisi, J., & Sun, Y. (2023) · Aging Cell · doi:10.1111/acel.13921 · Cited by 146
Self-citationThe Role of Immune Cells in Oxi-Inflamm-Aging
Martínez de Toda, I., Ceprián, N., Díaz-Del Cerro, E., & De la Fuente, M. (2021) · Cells · doi:10.3390/cells10112974 · Cited by 120
“Through SASP, they release pro-inflammatory mediators to attract immune cells such as macrophages, natural killer cells, or cytotoxic T cells, which recognize and eliminate those non-functional or malignant cells [68], promoting body homeostasis.”
BackgroundKandhaya‐Pillai, R., Yang, X., Tchkonia, T., Martin, G. M., Kirkland, J. L., & Oshima, J. (2022) · Aging Cell · doi:10.1111/acel.13646 · Cited by 119
“…trigger for a number of chronic diseases; senescent cells themselves can act as a source of chronic inflammation through their SASP (Coppé et al., 2010; Freund et al., 2010; Pignolo et al., 2020; Song et al., 2020; Tchkonia et al., 2021; Tchkonia & Kirkland, 2018; Wissler Gerdes et al., 2020).”
BackgroundSelf-citationGaikwad, S., Senapati, S., Haque, M. A., & Kayed, R. (2024) · Alzheimer's & Dementia · doi:10.1002/alz.13490 · Cited by 117
Large-scale chromatin reorganization reactivates placenta-specific genes that drive cellular aging
Liu, Z., Ji, Q., Ren, J., Yan, P., Wu, Z., Wang, S., Sun, L., Wang, Z., Li, J., Sun, G., et al. (2022) · Developmental Cell · doi:10.1016/j.devcel.2022.05.004 · Cited by 109
Role of cellular senescence in inflammation and regeneration
Saito, Y., Yamamoto, S., & Chikenji, T. (2024) · Inflammation and Regeneration · doi:10.1186/s41232-024-00342-5 · Cited by 139
“Cellular senescence contributes to aging and age-related diseases [7].”
BackgroundTargeting senescent cells for a healthier longevity: the roadmap for an era of global aging
Sun, Y., Li, Q., & Kirkland, J. L. (2022) · Life Medicine · doi:10.1093/lifemedi/lnac030 · Cited by 105
Self-citationStrategies for late phase preclinical and early clinical trials of senolytics
Wissler Gerdes, E. O., Misra, A., Netto, J. M. E., Tchkonia, T., & Kirkland, J. L. (2021) · Mechanisms of Ageing and Development · doi:10.1016/j.mad.2021.111591 · Cited by 103
Self-citationLiu, H., Zhao, H., & Sun, Y. (2021) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2021.11.004 · Cited by 108
Self-citationDeryabin, P. I., & Borodkina, A. V. (2022) · Human Reproduction · doi:10.1093/humrep/deac112 · Cited by 109
Macroautophagy and aging: The impact of cellular recycling on health and longevity
Nieto-Torres, J. L., & Hansen, M. (2021) · Molecular Aspects of Medicine · doi:10.1016/j.mam.2021.101020 · Cited by 99
Inflamm-ageing: How cytokines and nutrition shape the trajectory of ageing
Coperchini, F., Greco, A., Teliti, M., Croce, L., Chytiris, S., Magri, F., Gaetano, C., & Rotondi, M. (2024) · Cytokine & Growth Factor Reviews · doi:10.1016/j.cytogfr.2024.08.004 · Cited by 99
Inflammaging and Immunosenescence as Part of Skin Aging—A Narrative Review
Pająk, J., Nowicka, D., & Szepietowski, J. C. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24097784 · Cited by 91
“Senomorphics should be administered continuously to maximize their effect [41].”
BackgroundFasting: From Physiology to Pathology
Tang, D., Tang, Q., Huang, W., Zhang, Y., Tian, Y., & Fu, X. (2023) · Advanced Science · doi:10.1002/advs.202204487 · Cited by 86
Aging of Liver in Its Different Diseases
Radonjić, T., Dukić, M., Jovanović, I., Zdravkovic, M. D., Mandić, O., Popadić, V., Popović, M., Nikolić, N., Klašnja, S., Divac, A., et al. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms232113085 · Cited by 83
“C/EBPβ has as a target the synthesis of IL-6 and its inactivation leads to a reduction in the inflammatory effect of SASP.”
BackgroundInfluentialHallmarks and Biomarkers of Skin Senescence: An Updated Review of Skin Senotherapeutics
Bulbiankova, D., Díaz‐Puertas, R., Álvarez‐Martínez, F. J., Herranz‐López, M., Barrajón‐Catalán, E., & Micol, V. (2023) · Antioxidants · doi:10.3390/antiox12020444 · Cited by 75
Zhang, P., Chua, N. Q. E., Dang, S., Davis, A., Chong, K. W., Prime, S. S., & Cirillo, N. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23031637 · Cited by 67
“These drugs include BCL-XL inhibitors, finestin, ouabain, quecertin and dasatinib [102].”
BackgroundLv, Y., Wu, L., Jian, H., Zhang, C., Lou, Y., Kang, Y., Hou, M., Li, Z., Li, X., Sun, B., et al. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.997765 · Cited by 67
Mbara, K. C., Devnarain, N., & Owira, P. M. O. (2022) · Pharmaceutical Medicine · doi:10.1007/s40290-022-00444-w · Cited by 47
“The primary strategic approach of senomorphics is the targeting of regulatory pathways associated with SASP expressions, such as the p38 mitogen-activated protein kinase (MAPK), phosphatidylinositol 3-kinase/serine/threonine protein kinase (PI3K/ Akt), mechanistic target of rapamycin (mTOR), and the Janus kinase-signa…”
BackgroundTargeting Cellular Senescence for Healthy Aging: Advances in Senolytics and Senomorphics
Alum, E., Izah, S., Uti, D., Ugwu, O., Betiang, P., Basajja, M., & Ejemot-Nwadiaro, R. (2025) · Drug Design, Development and Therapy · doi:10.2147/dddt.s543211 · Cited by 63
Diverse Roles of Cellular Senescence in Skeletal Muscle Inflammation, Regeneration, and Therapeutics
Saito, Y., & Chikenji, T. (2021) · Frontiers in Pharmacology · doi:10.3389/fphar.2021.739510 · Cited by 56
“In geriatric mice, MuSCs express high levels of SA-β-Gal and Cdkn2a, Cdkn2b, and Igfbp5 mRNA, resulting in impaired muscle regeneration after injury (Sousa-Victor et al., 2014).”
BackgroundInfluentialSenolytic therapeutics: An emerging treatment modality for osteoarthritis
Ansari, M. M., Ghosh, M., Lee, D., & Son, Y. (2024) · Ageing Research Reviews · doi:10.1016/j.arr.2024.102275 · Cited by 57
Xu, Q., & Chen, Y. (2021) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2021.685379 · Cited by 46
“Cellular senescence often triggers an immune response in the tumor microenvironment (Song et al., 2020), and immune cell infiltration into the tumor microenvironment promotes tumor growth (Sarode et al.”
BackgroundTowards AI-driven longevity research: An overview
Marino, N., Putignano, G., Cappilli, S., Chersoni, E., Chadha, A. S., Calabrese, G., Bischof, E. Y., Vanhaelen, Q., Zhavoronkov, A. A., Scarano, B., et al. (2023) · Frontiers in Aging · doi:10.3389/fragi.2023.1057204 · Cited by 52
“The most wellknown of these compounds are called “senolytics”, a new family of natural compounds such as Dasatinib and Quercetin, that could be useful to neutralize senescent cells (Song et al., 2020).”
BackgroundKiriyama, Y., Tokumaru, H., Sadamoto, H., Kobayashi, S., & Nochi, H. (2024) · Molecules · doi:10.3390/molecules29215102 · Cited by 52
The Emerging Role of Accelerated Cellular Senescence in Periodontitis
Aquino-Martínez, R. (2023) · Journal of Dental Research · doi:10.1177/00220345231154567 · Cited by 45
“Similarly, physical dysfunction in patients with idiopathic pulmonary fibrosis can be alleviated using senolytic agents (Song et al. 2020).”
BackgroundWang, X., Li, X., Zhou, J., Lei, Z., & Yang, X. (2024) · Chemico-Biological Interactions · doi:10.1016/j.cbi.2024.110890 · Cited by 40
Wang, X., Cai, Y., Wu, C., Liang, J., Tang, K., Lin, Z., Chen, L., Lu, Y., & Wang, Q. (2023) · Journal of Nanobiotechnology · doi:10.1186/s12951-023-02036-5 · Cited by 41
Senescent endothelial cells: a potential target for diabetic retinopathy
Liao, Y.-L., Fang, Y., Sun, J., & Dou, G. (2024) · Angiogenesis · doi:10.1007/s10456-024-09943-7 · Cited by 45
“Generally, senomorphics target certain components of SASP pathways that lead to the production of SASP factors through NF-κB, JAK, SIRT1, mTOR, or other pathways involved in the induction and maintenance of the SASP [156].”
Zhang, H., Xu, Q., Jiang, Z., Sun, R., Wang, Q., Liu, S., Luan, X., Campisi, J., Kirkland, J. L., Zhang, W., et al. (2025) · Advanced Science · doi:10.1002/advs.202412950 · Cited by 56
Self-citationAnti-aging: senolytics or gerostatics (unconventional view)
Blagosklonny, M. V. (2021) · Oncotarget · doi:10.18632/oncotarget.28049 · Cited by 40
Effects of Fisetin Treatment on Cellular Senescence of Various Tissues and Organs of Old Sheep
Huard, C., Gao, X., Hazra, M. E. D., Hazra, R.-O. D., Lebsock, K., Easley, J. T., Millett, P. J., & Huard, J. (2023) · Antioxidants · doi:10.3390/antiox12081646 · Cited by 41
Targeting senescent cells to reshape the tumor microenvironment and improve anticancer efficacy
Jiang, B., Zhang, W., Zhang, X., & Sun, Y. (2024) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2024.05.002 · Cited by 39
Self-citationMamun, A. A., Sufian, M. A., Uddin, M. S., Sumsuzzman, D. M., Jeandet, P., Islam, M. S., Zhang, H., Kong, A. T., & Sarwar, M. S. (2022) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2022.174991 · Cited by 40
Młynarska, E., Kowalik, A., Krajewska, A., Krupińska, N., Marcinkowska, W., Motor, J., Przybylak, A., Tłustochowicz, K., Rysz, J., & Franczyk, B. (2025) · Biomolecules · doi:10.3390/biom15101452 · Cited by 41
Klinngam, W., Rungkamoltip, P., Thongin, S., Joothamongkhon, J., Khumkhrong, P., Khongkow, M., Namdee, K., Tepaamorndech, S., Chaikul, P., Kanlayavattanakul, M., et al. (2021) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2021.112461 · Cited by 38
Xia, Y., Li, J., Wang, L., Xie, Y., Zhang, L., Han, X., Tan, W., & Liu, Y. (2022) · Angewandte Chemie International Edition · doi:10.1002/anie.202214169 · Cited by 34
Nanocarriers for natural polyphenol senotherapeutics
Joma, N., Bielawski, P., Saini, A., Kakkar, A. K., & Maysinger, D. (2024) · Aging Cell · doi:10.1111/acel.14178 · Cited by 36
Branched‐Chain Amino Acid Accumulation Fuels the Senescence‐Associated Secretory Phenotype
Liang, Y., Pan, C. C., Yin, T., Wang, L., Gao, X., Wang, E., Quang, H., Huang, D., Tan, L., Xiang, K., et al. (2023) · Advanced Science · doi:10.1002/advs.202303489 · Cited by 44
Miller, S., Campbell, C. E., Jimenez-Corea, H. A., Wu, G., & Logan, R. A. (2022) · Frontiers in Neuroscience · doi:10.3389/fnins.2022.824191 · Cited by 37
Yin, S., Lin, S., Xu, J., Yang, G., Chen, H., & Jiang, X. (2023) · Journal of Nanobiotechnology · doi:10.1186/s12951-023-02085-w · Cited by 31
Van houcke, J., Mariën, V., Zandecki, C., Ayana, R., Pepermans, E., Boonen, K., Seuntjens, E., Baggerman, G., & Arckens, L. (2023) · npj Regenerative Medicine · doi:10.1038/s41536-023-00304-4 · Cited by 29
“Senescent cells accumulate with age as a response to multiple stressors such as increasing DNA damage, telomeric attrition and other oncogenic events 30,31 .”
Feng, M., Xu, H., Zhou, W., & Pan, Y. (2023) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-023-02615-2 · Cited by 32
Understanding cellular senescence: pathways involved, therapeutics and longevity aiding
Kumar, A., & Thirumurugan, K. (2023) · Cell Cycle · doi:10.1080/15384101.2023.2287929 · Cited by 31
“As a result of paracrine effects caused by SASP, these non-proliferating, static senescent cells occupy critical niches in the cellular milieu, inhibiting the proliferation of healthy cells and encouraging tissue failure [189–191].”
BackgroundLiu, J., Zheng, R.-Q., Wang, Y., Liu, Y., Jiang, S., Wang, X., He, K., Pan, X., Zhou, T., Li, T., et al. (2022) · Metabolites · doi:10.3390/metabo12020177 · Cited by 25
“Aging, a universal physiological phenomenon, is comprehensive manifestation of the decline and disorder in both structural homeostasis and functional integrity, gradually resulting in health impairment [1].”
BackgroundSenescent AECⅡ and the implication for idiopathic pulmonary fibrosis treatment
Zhang, T., Zhang, J., Lv, C., Li, H., & Song, X. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2022.1059434 · Cited by 29
“Therefore, senomorphics need to be taken for a long period to achieve maximum intervention, and the potential risks and adverse effects of senomorphics are greater than those of senolytics (Song et al., 2020).”
BackgroundInfluentialTargeting Vascular Smooth Muscle Cell Senescence: A Novel Strategy for Vascular Diseases
Lin, M., Hu, S.-L., Tian, Y., Jing, Z., Liang, N., Sun, R., Gong, S.-X., & Wang, A. (2023) · Journal of Cardiovascular Translational Research · doi:10.1007/s12265-023-10377-7 · Cited by 24
“The first approach is to target pathways associated with SASP such as the p38MAPK, P13K/AKT, mTOR, and JAK/STAT pathways and transcription factors which include NF-κΒ and STAT [118].”
BackgroundZhou, H., Khan, D., Gerdes, N., Hagenbeck, C., Rana, M., Cornelius, J. F., & Muhammad, S. (2023) · Antioxidants · doi:10.3390/antiox12040960 · Cited by 22
“The abolition of senescent cells has been shown to increase lifespan and provide protection against cardiovascular and age-related diseases in experimental animal studies [3,6].”
BackgroundInfluentialLiu, H., Zhao, D. H., Li, H., Zhang, W., Lin, Q., Wang, X., Zheng, S., Zhang, L., Li, L., Hu, S., et al. (2022) · Cell Death and Disease · doi:10.1038/s41419-022-04611-4 · Cited by 27
Kim, S., Park, G., Kim, D., Hasan, M. S., Lim, C., Seu, M., & Ryu, J. (2024) · Advanced NanoBiomed Research · doi:10.1002/anbr.202300137 · Cited by 20
Zhang, Y., & Zhou, Y. (2024) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2024.117314 · Cited by 23
A New Landscape of Human Dental Aging: Causes, Consequences, and Intervention Avenues
Xie, Y., Chen, S., Sheng, L., Sun, Y., & Liu, S. (2022) · Aging and Disease · doi:10.14336/ad.2022.1224 · Cited by 32
“pathways: the p53-p21(CDKN1A)-retinoblastoma (RB) axis and the p16(CDKN2A)-RB branch [16].”
BackgroundSelf-citationCordiano, R., Caserta, S., Minciullo, P. L., Allegra, A., & Gangemi, S. (2025) · Molecules · doi:10.3390/molecules30061251 · Cited by 27
“Excessive ROS production further pushes cells into a senescence-associated secretory phenotype (SASP), characterized by producing pro-inflammatory mediators and recruiting immune cells [53].”
Li, X., Khan, D., Rana, M., Hänggi, D., & Muhammad, S. (2022) · Antioxidants · doi:10.3390/antiox11122413 · Cited by 18
“Animal studies have shown that the elimination of senescent cells provided protection against age-related diseases and increased life span [5].”
BackgroundInfluentialAnsari, A., Walton, S. L., & Denton, K. M. (2023) · Biology of Sex Differences · doi:10.1186/s13293-023-00519-6 · Cited by 20
“Cells exposed to stressors, such as oxidative stress, hypoxia or inflammation, are all factors associated with hypertension entering cellular senescence [8].”
BackgroundUnraveling the ROS-Inflammation-Immune Balance: A New Perspective on Aging and Disease
Fang, S., Jiang, M., Jiao, J., Zhao, H., Liu, D., Gao, D., Wang, T., Yang, Z. X., & Yuan, H. (2025) · Aging and Disease · doi:10.14336/ad.2024.1253 · Cited by 30
“In the SASP, proinflammatory mediators are released to recruit immune cells including macrophages, cytotoxic T cells or natural killer (NK) cells [46].”
Sun, Y. (2023) · Translational Medicine of Aging · doi:10.1016/j.tma.2023.06.001 · Cited by 16
Self-citationRadak, M., & Fallahi, H. (2023) · Biogerontology · doi:10.1007/s10522-023-10039-w · Cited by 16
“Therefore, targeting senescent cells has emerged as a potential strategy for promoting healthy aging and preventing age-related diseases (Song et al. 2020).”
BackgroundThe Quest for Eternal Youth: Hallmarks of Aging and Rejuvenating Therapeutic Strategies
Nunkoo, V. S., Cristian, A., Jurcău, A., Diaconu, R. G., & Jurcău, M. C. (2024) · Biomedicines · doi:10.3390/biomedicines12112540 · Cited by 19
Xing, J., Chen, K., Gao, S., Pousse, M., Ying, Y., Wang, B., Chen, L., Wang, C., Wang, L., Hu, W., et al. (2023) · Aging Cell · doi:10.1111/acel.13780 · Cited by 19
“A wealth of recent research indicates that cellular senescence is a basic aging process that greatly contributes to health deterioration and thereby critically impedes healthy aging (Baker et al., 2016; Childs et al., 2017; Song et al., 2020; Tchkonia et al., 2021).”
BackgroundGong, Q., Jiang, Y., Xiong, J., Liu, F., & Guan, J. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1199002 · Cited by 15
A Senomorphic‐Conjugated Scaffold for Application of Senescent Cells in Regenerative Medicine
Deng, W., Jun-ichiro, J. O., Tanaka, T., Morikuni, H., Hashimoto, Y., Matsumoto, N., & Honda, Y. (2023) · Advanced Therapeutics · doi:10.1002/adtp.202200276 · Cited by 14
Wang, P., Wang, R., Huo, Y., Peng, Y. H., Fu, C., Hu, Y., Ren, Z., Mulat, Y., Zhang, H., Jiang, D., et al. (2025) · Advanced Science · doi:10.1002/advs.202511019 · Cited by 15
Shen, X., Wang, M., Chen, W., Xu, Y., Zhou, Q., Zhu, T., Wang, G., Cai, S., Han, Y., Xu, C., et al. (2023) · Aging · doi:10.18632/aging.204524 · Cited by 12
“Generally, the immune response is one of the most important results of cellular senescence [27, 28], which induces the enrichment of immune cells and promotes tumor growth [29].”
BackgroundChen, X., Walton, K. L., Brodaty, H., & Chalton, K. (2024) · Journal of Alzheimer s Disease · doi:10.3233/jad-231222 · Cited by 13
“Theoptimaldosingregimenfornutritionsenother-apeuticagentsremainunclear[70].”
Tauroursodeoxycholic acid targets HSP90 to promote protein homeostasis and extends healthy lifespan
Liu, J., Wang, Y., Guo, Y., Zheng, R.-Q., Wang, Y., Shen, Y., Liu, Y., Cao, A.-P., Wang, R., Xie, B.-Y., et al. (2024) · Science China Life Sciences · doi:10.1007/s11427-024-2717-6 · Cited by 13
“The imbalance in structural homeostasis and the decline in functional integrity impair health, leading to various age-related diseases such as muscle atrophy and neurodegenerative disorders (Kirkwood, 2005; López-Otín et al., 2013; Song et al., 2020).”
Kendirci, R., Satı, L., & Çelik-Özenci, Ç. (2024) · Journal of Assisted Reproduction and Genetics · doi:10.1007/s10815-024-03207-5 · Cited by 12
“In senotherapy, which aims to reverse or stop the pathological state, SASP secretion is inhibited by senomorphic treatments [17].”
BackgroundIs Senolytic Therapy in Cardiovascular Diseases Ready for Translation to Clinics?
Yang, Z., Potenza, D. M., & Ming, X. (2025) · Biomolecules · doi:10.3390/biom15040545 · Cited by 13
“Multiple senescent cell types, including endothelial cells, vascular smooth muscle cells, and immune cells, including foam cells, macrophages, and T-cells, are strongly associated and correlated with atherosclerosis [27,28,49–52].”
Mun, S., Jang, C. J., Jo, S. B., Park, S.-H., Sim, H. B., Ramos, S., Kim, H. J., Choi, Y.-J., Park, D.-H., Park, K.-W., et al. (2024) · Animal Cells and Systems · doi:10.1080/19768354.2024.2374547 · Cited by 10
“The aging population is a new global issue, and active research has been conducted on various dietary supplements aimed at healthy aging (Wahlqvist and Saviage 2000; Warren 2010; Kim et al. 2016; Song et al. 2020).”
BackgroundKaren‐Ng, L. P., Ahmad, U. S., Gomes, L., Hunter, K. D., Wan, H., Hagi‐Pavli, E., & Parkinson, E. K. (2022) · Cancers · doi:10.3390/cancers14112636 · Cited by 8
“Senolytics targeting MPPOL may be re548 quired, as cell type specificity of this class of drug has already been observed [56].”
BackgroundSingh, I., & Singh, A. K. (2025) · Molecular Neurobiology · doi:10.1007/s12035-025-05504-1 · Cited by 11
“Hence, there is an antibody, ABX-IL-8, that is designed to target the IL-8-secreting pathway, thus preventing its release [90].”
Downregulation of Krüppel‐like factor 14 accelerated cellular senescence and aging
Hou, Y., Song, Q., Wang, Y., Liu, J., Cui, Y., Zhang, X., Zhang, J., Fu, J., Cao, M., Zhang, C., et al. (2023) · Aging Cell · doi:10.1111/acel.13950 · Cited by 7
“Cumulative evidence has demonstrated that cellular senescence is a key hallmark of aging, which plays a crucial role in controlling aging and aging-associated diseases (Song et al., 2020).”
BackgroundXu, W., Xiang, X., Lin, L., Gong, Z., & Xiao, W. (2023) · Journal of the Science of Food and Agriculture · doi:10.1002/jsfa.13096 · Cited by 8
Exploring the Antiaging Properties of Curcumin, Flaxseed, and Collagen: A Comprehensive Review
Varma, P., & Kandasubramanian, B. (2024) · ChemistrySelect · doi:10.1002/slct.202403395 · Cited by 8
Liu, X., Zhou, J., Hou, Q., Zhou, Z., & Bai, Y. (2025) · Immunity & Ageing · doi:10.1186/s12979-025-00552-6 · Cited by 11
“Aging involves a progressive physiological decline that results in cellular dysfunction and increased susceptibility to age-related disorders [1].”
Senolytics: Opening avenues in drug discovery to find novel therapeutics for Parkinson’s Disease
Kakoty, V., Chandran, S. K., Gulati, M., Goh, B. H., Dua, K., & Singh, S. K. (2023) · Drug Discovery Today · doi:10.1016/j.drudis.2023.103582 · Cited by 8
Should We Consider Water and Antibiotics to Be Geroprotectors?
Khokhlov, A. N., & Васильевна, М. Г. (2023) · Advances in Gerontology · doi:10.1134/s2079057024600460 · Cited by 7
“The significant interest in the study of so-called senolytics and senomorphics that has arisen in recent years has led to the appearance of a large number of works, the authors of which conclude that such compounds can be good geroprotectors [24, 25].”
Rademacher, D. J., Exline, J. E., & Foecking, E. M. (2025) · Biomedicines · doi:10.3390/biomedicines13061400 · Cited by 9
Xu, Q., Li, G., Zhang, H., Jiang, Z., Gao, X., Li, Z., Prata, L. G. P. L., Kirkland, J. L., Zhang, G., & Sun, Y. (2026) · Nature Communications · doi:10.1038/s41467-026-70302-9 · Cited by 7
“Studies focusing on synthetic fl a-vones suggested that hydroxyl substitutions at C-2 ’ ,3 ’ ,4 ’ ,5 and 7 are critical for inhibiting the SASP 9 .”
Self-citationGui, C., Wei, J., Mo, C., Liang, Y., Cen, J., Chen, Y., Wang, D., & Luo, J. (2023) · International Journal of Biological Sciences · doi:10.7150/ijbs.85209 · Cited by 6
“Based on the abovementioned analyses, we found that the three AME regulatory patterns had notably distinct TME cell infiltration phenotypes.”
InfluentialOral Senescence: From Molecular Biology to Clinical Research
Parkinson, E. K., & Prime, S. S. (2022) · Frontiers in Dental Medicine · doi:10.3389/fdmed.2022.822397 · Cited by 7
Cellular Senescence in Kidney Diseases: From Bench to Clinic
Shu, S., Liu, J., Qian, Y., & Zhang, C. (2025) · The FASEB Journal · doi:10.1096/fj.202503532r · Cited by 7
“Cellular senescence in the tumor microenvironment can promote tumorigenesis and tumor progression [213, 214].”
Senolytic drugs: implications for clinical practice
Константиновна, И. А., Matchekhina, L. V., Ткачева, О. Н., Владимировна, Б. А., Melnitskaia, A. A., Churov, A. V., & Strazhesko, I. D. (2023) · Problems of Geroscience · doi:10.37586/2949-4745-1-2023-7-14 · Cited by 6
Aging and anti-aging strategies: A review of past and future therapeutics
Wei, Y., Xiong, B., Song, Z., Zhong, S., Zheng, N., Zhang, A., Chen, Y., & Sun, H. (2025) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2025.118340 · Cited by 4
Xia, Y., Li, J., Wang, L., Xie, Y., Zhang, L., Han, X., Tan, W., & Liu, Y. (2022) · Angewandte Chemie · doi:10.1002/ange.202214169 · Cited by 4
Wang, D., Ning, H., Wu, H., Song, Y., Chu, Y., Liu, F., Zhao, Z., Wu, F., & Lyu, J. (2023) · Current Urology · doi:10.1097/cu9.0000000000000218 · Cited by 5
Cellular Senescence in Cancer: Mechanisms, Roles in Tumor Progression, and Therapeutic Implications
Yan, J., Zhang, Y., Mao, G., Yu, J., Zhou, T., & Hao, J. (2025) · MedComm – Oncology · doi:10.1002/mog2.70029 · Cited by 3
New frontier for epilepsy treatment through targeting cellular senescence
Bello, S. T., Rafe, M. R., & Huang, F. (2025) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2025.111506 · Cited by 3
Lee, W., Song, G., & Bae, H. (2026) · Biochemical Pharmacology · doi:10.1016/j.bcp.2026.117672 · Cited by 4
Chen, L., Li, J., Wang, S., Ren, R., Xiong, W., Gan, X., Kang, H., Wen, Y., Li, J., & He, L. (2026) · International Immunopharmacology · doi:10.1016/j.intimp.2026.116450 · Cited by 4
Farrokhi, V., Afrisham, R., Soleimani, M., Ahmadvand, M., Mousavi, S. H., Kashanikhatib, Z., Owchi, S., Mohammadali, F., & Alizadeh, S. (2024) · The Natural Products Journal · doi:10.2174/0122103155285692240301052306 · Cited by 5
Advancing Single-Cell Detection of Senescent Cells: Laboratory Methods and Clinical Applications
Lung, S. H., & Lung, T. (2025) · OBM Geriatrics · doi:10.21926/obm.geriatr.2502307 · Cited by 4
Metadata
- Authors
- Song, S., Tchkonia, T., Jiang, J., Kirkland, J. L., & Sun, Y.
- Affiliations
- Binzhou Medical University (CN)
- Robert and Arlene Kogod Center on Aging Mayo Clinic Rochester MN 55905 USA
- Mayo Clinic (US)
- Corresponding author
- Sun, Yu
- Venue
- Advanced Science
- Publisher
- Wiley
- Published
- 2020-10-19
- Volume
- 7
- Issue
- 23
- Pages
- 2002611-2002611
- ISSN
- 2198-3844 (ISSN-L)
- PMC
- PMC7709980
- OpenAlex
- W3093572772
- Cited by
- 129
- References
- 162
- Citations by year
- 2026: 10 · 2025: 20 · 2024: 23 · 2023: 40 · 2022: 23 · 2021: 12 · 2020: 1
- FWCI
- 2.42
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- cc-by
- creativecommons.org/licenses/by/4.0/ (am)
- creativecommons.org/licenses/by/4.0/ (vor)
- doi.wiley.com/10.1002/tdm_license_1.1 (tdm)
- Locations
- Advanced Science (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Funders
- National Key Research and Development Program of China (2016YFC1302400, 2019YFC2002801)
- National Natural Science Foundation of China (81472709, 31671425, 31871380)
- Science and Technology Commission of Shanghai Municipality (20XD1404300)
- U.S. Department of Defense (PC111703)
- National Institutes of Health (R37‐AG013925, P01 AG062413)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Telomeres, Telomerase, and Senescence
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Aging › Genetics, Aging, and Longevity in Model Organisms
- Health Sciences › Medicine › Geriatrics and Gerontology › Sirtuins and Resveratrol in Medicine
- Keywords
- cellular senescence, senolytics, senotherapy, healthy aging, age-related diseases, cell cycle arrest, senolytic therapy, precision medicine
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.